Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) General Information
Description
Portfolio of cardiovascular disease drug patents.
Contact Information
Corporate Office
- Planegg
- Germany
Corporate Office
- Planegg
- Germany
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) FAQs
-
Where is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) headquartered?
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is headquartered in Planegg, Germany.
-
What industry is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) in?
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s primary industry is Buildings and Property.
-
Is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) a private or public company?
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is a Private company.
-
What is Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s current revenue?
The current revenue for Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) is .
-
Who are Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)’s investors?
Secarna Pharmaceuticals has invested in Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent).
-
When was Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) acquired?
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) was acquired on 23-Mar-2020.
-
Who acquired Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent)?
Secarna Pharmaceuticals (Portfolio of Cardiovascular Disease Drug Patent) was acquired by Lipigon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process